Publications

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Automated prospective quality assurance of tumor segmentation and treatment planning in the hypo-FLAME 3.0 trial.

Neuro-oncology practice

Symptom burden in young adult brain tumor survivors: Key intervention targets based on patient-reported outcome network analyses.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Dose-based evaluation of delineation variation in radiotherapy: A scoping review.

Annals of surgical oncology

ASO Visual Abstract: Patient and Tumor Factors Influencing Diagnostic Trajectories in Gastrointestinal Stromal Tumor Patients and Their Impact on Health-Related Quality of Life: A Dutch Multicenter Study.

European radiology

Diagnostic assessment of artificial intelligence reconstruction on accelerated prostate MRI: a retrospective, paired, multi-reader multi-case study.

Cancer epidemiology

Image-based consensus molecular subtypes and colon cancer recurrence: Understanding the impact of lifestyle factors across subtypes of colon cancer.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Acute and long-term toxicity profiles and final oncologic outcomes in the phase III ARTFORCE trial.

Annals of surgical oncology

Patient and Tumor Factors Influencing Diagnostic Trajectories in Gastrointestinal Stromal Tumor Patients and Their Impact on Health-Related Quality of Life: A Dutch Multicenter Study.

European journal of cancer (Oxford, England : 1990)

Papillary renal cell carcinoma - exploratory results of the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first line therapy based on central pathological review.

26-07-2026

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Reply to: In DeFi-ance of "More Is Better": Questioning Long-Term Nirogacestat Use in Desmoid Tumors.

20-07-2026

Cancer research

Arginine Deprivation of ASS1-Deficient Cancers Drives Mistranslation and Shared Neoepitope Production.

15-07-2026

Journal of cancer survivorship : research and practice

Knowledge gaps among adult Hodgkin lymphoma survivors: implications for risk‑based care.

15-07-2026

Trends in cancer

Neoadjuvant immunotherapy in breast cancer: Progress and challenges.

15-07-2026

Cell reports. Medicine

Tryptophan degradation by intestinal Bacteroides induces anti-tumor immunity and limits melanoma growth.

14-07-2026

Clinical cancer research : an official journal of the American Association for Cancer Research

The pharmacological profile of ART6043, a first-in-class clinical DNA polymerase theta polymerase domain inhibitor potentiating PARP inhibitor efficacy.

13-07-2026

Cancer cell

Targeting tumor-intrinsic STK40 induces immune vulnerability and drives T cell reinvigoration.

13-07-2026

European journal of nuclear medicine and molecular imaging

Real-world use of PSMA imaging in metastatic castration-sensitive prostate cancer: Findings from the CAPRI-3 registry.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Response prediction after neoadjuvant chemoradiotherapy in esophageal cancer using FDG-PET and multiparametric MRI: A prospective multicenter study.

Nature genetics

The PRECISE European initiative for cancer-vulnerability mapping and prediction.

Journal of the National Cancer Institute

Neoadjuvant immunotherapy for resectable cutaneous melanoma: a nationwide population-based cohort.

The EMBO journal

Alterations in chromatin organization promote totipotent-like features in a DPPA2/DUX-dependent manner.

09-07-2026

The Lancet. Oncology

Systemic therapy, gastrectomy, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy versus systemic therapy alone for gastric cancer with limited peritoneal metastases (PERISCOPE II): final results of a multicentre, randomised, controlled, phase 3 trial after an unplanned commissioned interim analysis.

08-07-2026

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Still Lost in Transition? A 20-Year Reflection on Cancer Survivorship Care.

08-07-2026

European urology oncology

MRI-based Response Assessment of Neoadjuvant Systemic Immunotherapy in Muscle-invasive Bladder Cancer: An Analysis of Inter-radiologist Variability and Diagnostic Accuracy in three Prospective Clinical Trials.

08-07-2026

Cell chemical biology

XPO1 inhibition induces NCOR1-Dependent oxidative stress to suppress hepatocellular carcinoma.

07-07-2026

Cancer chemotherapy and pharmacology

The use of pharmacodynamic results for recommended phase II decision making in oncology clinical trials.

06-07-2026

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer

Self-reported peripheral neuropathic symptoms in long-term adolescent and young adult (AYA) cancer survivors: results of the SURVAYA study.

02-07-2026

Cancer discovery

Germline CDK12 variants in aggressive prostate cancer.

02-07-2026

European journal of nuclear medicine and molecular imaging

Redefining robotic image-guidance - tomographic visualization of lesions during prostate cancer surgery via gantry-free robotic SPECT.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Human epididymis protein 4 and risk of malignancy index as risk assessment tools in the decision for referral to an oncology center in patients with an ovarian mass: a cost-effectiveness analysis from a Dutch health care perspective.

Pharmacological research

Daraxonrasib (RMC-6236) pharmacokinetics: impact of transporters and drug-metabolizing enzymes on a first-in-class pan-RAS molecular glue.

Transplantation and cellular therapy

Advancing Cell Therapies for Solid Tumors: A Pathway to Overcome Biological, Operational, and Regulatory Hurdles.

Radiology. Artificial intelligence

Tumor-preserving Deformable Registration of Longitudinal DCE Breast MRI during Neoadjuvant Chemotherapy.

Nature

TROP2 targeting reveals therapy-driven cell state dynamics in colorectal cancer.

Neuro-oncology advances

Cancer treatment-related cognitive impairment.

Clinical and translational radiation oncology

Predicting locoregional treatment failure in anal cancer using multivariable clinical-imaging models.

European urology open science

Corrigendum to "Long-term real-world survival outcomes with dual immune checkpoint blockade in synchronous metastatic renal cell carcinoma: implications for the design of prospective cytoreductive nephrectomy trials" [Eur. Urol. Open Sci. 83 (2026) 133-141].

European urology

European Association of Urology and American Society of Clinical Oncology Guidelines on Penile Cancer: A Summary of the 2026 Guidelines Update.

Radiography (London, England : 1995)

Independent patient access to imaging digital health records: Oncology patients' and healthcare professionals' views and preferences.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Diffusion weighted MRI-based hypoxic fraction as a prognostic factor in the FLAME trial prostate cancer cohort.

Trends in cancer

Watching cancer begin: emerging tools to visualize the first steps of tumorigenesis.

Annals of surgical oncology

Understanding Physical Functioning in Patients with Sarcoma After Amputation: Using an International Classification of Functioning, Disability and Health (ICF) Approach.

The Lancet. Oncology

Targeting homologous recombination deficiency with intensified chemotherapy versus standard chemotherapy followed by olaparib in stage III breast cancer (SUBITO): an open-label, randomised, controlled, phase 3 trial.

Thyroid : official journal of the American Thyroid Association

Prospective Predictors of Poor Emotional Functioning in Patients with Differentiated Thyroid Carcinoma.

Nature genetics

Insights from three decades of BRCA1/2 modeling in mice.

The Lancet. Oncology

Tailoring radiotherapy in cT1-2N1 breast cancer to nodal response on primary chemotherapy (RAPCHEM: BOOG 2010-03): 10-year follow-up results of a Dutch, prospective, registry study.